Clinical trials
catalyst calendar across sponsors →Studies where TDOC is the lead sponsor, as filed with ClinicalTrials.gov. Completion dates are the sponsor's own projected windows and are revised as a study runs. Active studies first, then completed and stopped — newest readout first within each.
1 interventional · 1 observational
Held by 14 tracked-famous managers (Point72 Asset Management, L.P., RENAISSANCE TECHNOLOGIES LLC, AQR CAPITAL MANAGEMENT LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, Man Group plc, +9 more) · FINRA short interest 4.0 days to cover (settled 2026-07-31) · insider 90d: 0 buys / 9 sells · government filings 180d: none disclosed
| Study | Phase | Status | Interventions | Conditions | Enrollment | Primary completion | Updated |
|---|---|---|---|---|---|---|---|
| Clinical Outcomes of a Digital Mental Health Intervention for Moderate/Severe Depression and AnxietyNCT07081061RecruitmentRandomized · Single-masked · Treatment | Not applicable | Not yet recruiting | Other: BetterHelp | Depression, Anxiety, Mental Health Issue, Mental Health Wellness 2 | 86 | Oct 2025 | 2025-07-23 |
| Validation of myStrength's Macropersonalization EngineNCT05417178observationalInter-rater reliability on primary focus area | — | Unknown status | Other: myStrength Macropersonalization Enginge | Depression, Anxiety, Trauma | 200 | 2022-12-31 | 2022-06-14 |
Primary completion is the date the sponsor filed with the registry — their own projection, revised whenever they revise it, unless the row is marked actual.
Source: ClinicalTrials.gov, retrieved 2026-08-19